Teva and Royalty Pharma have signed a deal worth up to $500 million to advance TEV-408, a drug being tested for vitiligo and ...

A red, itchy rash spread across the man's arms and chest, then worsened into erythroderma, a severe, widespread skin ...

Royalty Pharma and the US affiliate of Israel’s Teva Pharmaceutical Industries have announced a funding agreement of up to ...

Teva strikes a $500M funding deal with Royalty Pharma for the speedy development of its vitiligo candidate, TEV-'408, while ...

Teva has penned a second pact with Royalty Pharma, this time securing up to $500 million to support the clinical development ...

Discover how diet impacts psoriasis. Learn about anti-inflammatory foods like those in the Mediterranean diet and their role in managing symptoms and improving health.

Gut health goes far beyond digestion. Experts explain how your gut influences mood, skin health and immunity and why caring ...

Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 million, to support Teva's anti-IL-15 candidate, TEV-'408 TE ...

A case has emerged of a person developing complete body hair loss and an inability to sweat after getting a tattoo. Research ...

Objective Sjögren’s is a chronic systemic autoimmune disease characterised by dryness symptoms (eyes, mouth, skin), alongside ...

Opinion - Hypertension is increasing worldwide and has reached epidemic proportions, largely due to modern lifestyle factors. Sedentary work, obesity, lack of physical activity, chronic stress, ...